You are here

oncology

AstraZeneca signs Alteogen deal worth up to $1.35B for subcutaneous cancer drugs despite Merck-Halozyme patent drama

Fierce Pharma

Mon, 03/17/25 - 10:11 pm

subcutaneous drug delivery

Drug developers ‘haven’t even scratched the surface’ of what radiopharma can do

Pharma Voice

Mon, 03/17/25 - 10:13 am

radiopharmaceuticals

Ratio Therapeutics

Radiopharm Theranostics

‘I don't feel we lost momentum’: Takeda’s oncology execs sharpen focus after restructuring

Fierce Biotech

Thu, 03/13/25 - 11:21 pm

Project Optimus: helping or hindering cancer drug development?

Clinical Trials Arena

Thu, 03/6/25 - 10:06 pm

Project Optimus

drug development

Its CEO died. The company scrapped a promising program. Now, for their 2nd act.

Pharma Voice

Thu, 02/27/25 - 10:12 am

Terns Pharmaceuticals

Pfizer taps a former Novartis exec to lead cancer drug push

BioPharma Dive

Thu, 02/6/25 - 11:38 am

Move Over Mounjaro. Eli Lilly Has Another Blockbuster Opportunity in the Making, and No One Is Talking About It.

Motley Fool

Sun, 01/26/25 - 04:13 pm

J&J oncology sales grow, but shares slide on outlook

BioPharma Dive

Wed, 01/22/25 - 12:01 pm

Multiple Myeloma

Pfizer, under pressure to change, names oncology head as new R&D chief

BioPharma Dive

Wed, 11/20/24 - 11:33 am

Pharma’s grip on cancer R&D is having unintended consequences

Pharma Voice

Wed, 11/13/24 - 10:52 am

After Pfizer deal, former Seagen CEO returns to lead oncology startup

BioPharma Dive

Mon, 10/28/24 - 11:10 am

cancer immunotherapy

Pediatric cancer drug shortage: 5 things to know

Beckers Hospital Review

Fri, 10/18/24 - 10:16 am

Notable Labs files for bankruptcy, ending ambitions for Boehringer cancer drug

Fierce Biotech

Tue, 10/15/24 - 10:17 am

Boehringer Ingelheim

Regeneron takes the long-haul approach to oncology, stumbles and all

Pharma Voice

Thu, 10/10/24 - 09:52 am

Galecto buys leukemia drug from Bridge Medicines, drops bone cancer asset in strategic pivot

Fierce Biotech

Mon, 10/7/24 - 11:36 am

Bridge Medicine

Teva and mAbxience partner to develop biosimilar candidate for oncology

Pharmaceutical Technology

Fri, 10/4/24 - 09:28 am

Teva Pharmaceutical

Want better cancer treatments? Make biopharma more like Silicon Valley

BioPharma Dive

Wed, 09/25/24 - 11:53 am

At J&J, oncology R&D meets commercial strategy in a quest for new standards of care

Pharma Voice

Thu, 09/19/24 - 09:22 am

FDA drafts guidance on multiregional clinical trials in oncology

RAPS.org

Mon, 09/16/24 - 10:24 pm

clinical trials

With a new oncology head, Takeda revamps its R&D strategy

Pharma Voice

Tue, 08/27/24 - 10:54 am

Pages